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Radiology in the era of value‑based
healthcare: a multi‑society expert statement
from the ACR, CAR, ESR, IS3R, RANZCR,
and RSNA
Adrian P. Brady1,13*, Jaqueline A. Bello2,14, Lorenzo E. Derchi3,13, Michael Fuchsjäger4,13, Stacy Goergen5,15,
Gabriel P. Krestin6,16, Emil J. Y. Lee7,17, David C. Levin8,18†, Josephine Pressacco9,17, Vijay M. Rao8,18,
John Slavotinek10,15, Jacob J. Visser6,16, Richard E. A. Walker11,17 and James A. Brink12,14,16

Abstract
Background: The Value-Based Healthcare (VBH) concept is designed to improve individual healthcare outcomes
without increasing expenditure, and is increasingly being used to determine resourcing of and reimbursement for
medical services. Radiology is a major contributor to patient and societal healthcare at many levels. Despite this, some
VBH models do not acknowledge radiology’s central role; this may have future negative consequences for resource
allocation.
Methods, findings and interpretation: This multi-society paper, representing the views of Radiology Societies in
Europe, the USA, Canada, Australia, and New Zealand, describes the place of radiology in VBH models and the healthcare value contributions of radiology. Potential steps to objectify and quantify the value contributed by radiology to
healthcare are outlined.
Keywords: Radiology, Value, Value-based healthcare, Quality, Resources
Key points
• Value-based healthcare (VBH) is a framework for
improving individual patient health outcomes per
unit of expenditure.
• Radiology is a key component of healthcare, impacting greatly on patient outcomes, and must be considered a vital element of VBH.
• Embracing VBH principles, radiology can contribute
to moving to a value-driven system, where all investigations or interventions contribute positively to
patient outcomes.
*Correspondence: adrianbrady@me.com
†
David C. Levin is deceased
1
Mercy University Hospital, Cork, Ireland
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Introduction
In September 2020, members of this writing group published an article in JAMA on Radiology and Value-Based
Healthcare [1], intended to raise awareness among nonradiologists of the value contributed to healthcare by
radiology, and of ways that value can be harnessed and
enhanced by those who utilise and those who deliver
radiology services. This paper expands on that publication, in order to further explore the issues surrounding
value-based healthcare as they involve radiology, and is
primarily aimed at a radiology readership.
Value-based healthcare (VBH) has emerged in recent
years as a framework for improving individual patient
health outcomes per unit of expenditure [2, 3]. The impetus for this is, at least in part, the inexorable worldwide
rise in healthcare usage volume and associated costs,
increasing at a rate substantially greater than other
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cost-of-living inflation. The thrust of the VBH concept
is to continue to improve individual health outcomes
without commensurate increasing expenditure, by focusing on identification of practices that optimise the ratio
between health gained and healthcare cost. The goal is to
ensure that inflation does not make current healthcare
systems unsustainable, while maintaining or continually
improving patient outcomes.
US medical service funding is already influenced by
traditional cost-effectiveness analyses (CEA) and the
more recent VBH concept, as well as the related, but not
necessarily aligned, value-based payment (VBP) models [4]. CEA focuses on a single metric (incremental cost
effectiveness ratio, ICER) and is commonly used by policymakers to inform population—level decisions about
which procedures, pharmaceuticals or devices will be
funded or subsidised. “Value” in the context of VBH, on
the other hand, focuses on what is of value to the individual during a particular episode of care and its immediate aftermath. Consequently, it remains less well-defined,
with a wide range of proposed metrics. These patientcentred metrics are, in turn, not necessarily aligned with
VBPs (e.g. US Medicare and Medicaid Value-Based Payment Modifier), which often focus on short-term costs
to a specific payer of an episode of care. Criticisms of
such systems revolve around their inability to accurately
measure important patient outcomes and their potential
to exacerbate existing disparities in care delivery without
improving physician performance of healthcare delivery
[5].
The European Commission Expert Panel on Effective
Ways of Investing in Health has recently published a draft
Opinion Paper on “Defining Value in ‘value-based healthcare’”, which seeks to move the discussion away from
value-based pricing to a broader definition of VBH, based
on four pillars:
• appropriate care to achieve patients’ personal goals
(personal value)
• achievement of best possible outcomes with available
resources (technical value)
• equitable resource distribution across all patient
groups (allocative value)
• contribution of healthcare to social participation and
connectedness (societal value) [6]
Whatever the source of funding in any individual country, it is likely that healthcare institutions will be obliged
in the future to demonstrate that they apply VBH principles and optimise resource utilisation in order to ensure
continued funding. Therefore, not only is VBH a sensible approach to guide critical assessment of practices; it
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also will be key to services maintaining future financial
viability.
This paper, written by representatives of the European
Society of Radiology (ESR), American College of Radiology (ACR), Radiological Society of North America
(RSNA), Canadian Association of Radiologists (CAR),
Royal Australian and New Zealand College of Radiologists (RANZCR) and International Society for Strategic Studies in Radiology (IS3R), seeks to outline the
value contributed to healthcare by radiology, and to
explain how that value may be measured, recognised and
augmented.

Value‑based healthcare models
Porter’s original description of a VBH model listed an
outcome measure hierarchy containing three tiers (Sustainability of Health, Process of Recovery & Health Status achieved or retained), with many factors contributing
to each tier. The top tier (Sustainability) is considered
the most important, with lower-tier outcomes involving results contingent on higher-tier success [8]. In his
2010 NEJM paper outlining this model, Porter acknowledged that medical care “involves multiple medical specialties and numerous interventions”, and that “[m]uch
of the total cost of caring for a patient involves shared
resources, such as physicians, staff, facilities, and equipment” [7]. When calculations of value are used as a basis
for resourcing or reward, conflicts can develop between
different groups of contributors to care [1]. Porter writes:
“in a well-functioning health care system, the creation of
value for patients should determine the rewards for all
other actors in the system” [7].
Radiology is a vital part of modern medicine, a significant positive contributor to patient diagnosis and continuing care, and thus a key component of provision of
value. Furthermore, radiology as a specialty is the perfect
example of a healthcare resource shared across all levels
of healthcare delivery, all medical specialties, and patient
care at all ages [1]. Diagnostic radiology contributes value
in clinical workup by refining differential diagnoses formulated from history-taking, physical examination and
sometimes laboratory test results, thereby decreasing
the time required to initiate appropriate treatment, ultimately helping to reduce patient morbidity and mortality [8, 9]. In Porter’s VBH model, health gains and
reduced costs associated with decreased time in hospital, improved survival and lower utilisation of ineffective
treatments and investigations are not recognised as contributions made by radiology to the value of healthcare.
Nonetheless, short-term expenditures on imaging may
create long-term and system-wide cost savings and better
patient outcomes, none of which are credited to the value
of radiology according to this model.
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One extreme interpretation of the VBH model considers diagnostic radiology as a “cost centre”, whereby
all expenditures on imaging are perceived to negatively
contribute to value in healthcare, in the context of the
influence of errors or complications negatively affecting
outcomes in the Process of Recovery tier. Errors happen
in radiology, as they do in all branches of medicine, but
many reports of errors in radiology misunderstand the
diagnostic process, and apply biases to interpretation
after the fact, rather than reflecting the reality of interpretation of imaging data at a specific time, often based
on limited background information [3, 10]. This extreme
view values radiology’s contributions (if at all) in much
the same way as laboratory investigation outputs, ignoring much of the value created by the practice of radiology, and radiology’s clinical centrality to patient care.

Radiology’s place in value‑based healthcare
models
How, then, can we ensure that radiology is appreciated
not as a potential source of loss of value, but rather as an
intrinsic value creator?
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The most important way to do this is to quantify radiology’s impact on patient outcomes and on measurements
used historically by policymakers and other third party
payers, such as Quality Adjusted Life Years (QALYs)
and ICERs. In 1991 Fryback and Thornbury proposed a
6-level hierarchical value model starting with evidence
of technical efficacy at the lowest level and ending with
societal efficacy at the highest level [11] (Fig. 1). It is generally considered that adding value to patient care only
starts at level 4. However, much scientific literature relating to diagnostic radiology (as opposed to image-guided
therapy) relates to image acquisition and diagnostic accuracy, at levels 1 and 2, rather than to the contribution of
radiology, in concert with the entire system of delivery of
care, to the health outcomes of the patient or society as a
whole (the higher hierarchical levels). For instance, a high
quality MRI performed on well—maintained equipment
by a highly trained radiologist for a previously well 42—
year old patient reporting two weeks of non-specific low
back pain (effective at levels 1 & 2) may provide less net
benefit to individual or societal health than an average
quality head CT for a 25 year old painter who fell from a

Fig. 1 Hierarchical value model. (Reproduced with permission from Raja UA, Patel S, Singh LK, Shah D, Hamdulay S, Penn H, Remedios D. Early
arthritis ultrasound: a 4-year outcome study. ECR 2014, EPOS, https://doi.org/10.1594/ecr2014/C-2059)
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ladder and has a high pre-test clinical risk of intracranial
injury (effective at levels 3–6) [11].
Diagnostic Radiology faces special challenges in demonstrating a link between its key output, (making or
changing a diagnosis), and the final step in the value
chain, (improved health of the patient), due to the many
confounders along the pathway between diagnosis and
outcome.
Pathways exist for radiology providers to demonstrate
meaningful contributions to patient health outcomes,
or to have their funding/reimbursement influenced by
value-based activity. The US Medicare Access and CHIP
Reauthorization Act of 2015 (MACRA) established the
Quality Payment Program, under which eligible clinicians can participate via one of two tracks: Advanced
Alternative Payment Models (APMs); or the Merit-based
Incentive Payment System (MIPS). Both tracks involve
quality measures that demonstrate participation in certain quality improvement activities as well as contributions of radiology activity to patient care [12].
Considering the issues underpinning radiology value is
not a new idea. In 2009, Gunderman & Boland elegantly
outlined some of the reasons physicians or patients
might choose to use one radiology service over another
(perceived relative value), and some of the questions
radiologists might ask themselves when considering the
value they provide to patients [13]. In 2011, Rao & Levin
explained the value-based benefits to patients of single, cohesive, on-site radiology groups in hospitals, as
opposed to fragmented or out-sourced imaging services
[14]. Also in 2011, Gazelle et al. [15] proposed a framework to assess the value of diagnostic imaging in the
era of comparative effectiveness research. In 2016 Seidel et al. [16] described specific strategies for diagnostic
imaging to generate evidence and value.
Nobody in modern medical practice could imagine
attempting to function and maintain standards of clinical service in the absence of diagnostic imaging services,
including specialist radiologist interpretation, consultation and intervention. Radiology is a deeply-embedded
and essential part of modern patient care, at all levels of
service delivery and complexity, encompassing high-level
hospital-based medicine, primary care investigation,
screening and health-promotion activities. “Few episodes
of care occur without medical imaging, and a rational
health care system should define the distribution of revenue to radiology based on its value as derived from quality and costs” [17].
Radiology departments have the potential to be bottlenecks in any healthcare environment. A secondary analysis of the US National Hospital Ambulatory Medical Care
Survey (NHAMCS) from 2006 through 2008 demonstrated that when a physician ordered an ultrasound, CT,
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or MRI during an emergency department visit, the average length of stay for that patient increased by 56, 59, and
64 min respectively [18]. Under-resourced hospital-based
services can delay patient throughput and discharge.
Under-resourced primary-care and out-patient access to
imaging limits the capacity of non-hospital-based services to manage patients, resulting in increased reliance
on more expensive hospital-based facilities. Adequate
resourcing of radiology is vital to achieving or maintaining healthcare efficiency, and thus to maximising value.
Therefore, as part of the fundamental goal of enhancement of value for patients, radiology must be a component of any formula to assess costs against outcomes in
healthcare.

Value equation
Relating technical quality, service quality and price has
been defined as the radiology “value equation” [19].
What constitutes value in healthcare depends upon
who you ask. The University of Utah Health surveyed
patients, physicians and employers who pay for medical
benefits, in an effort to define how they perceive value.
Each group prioritised different value statements, reflecting the different viewpoints of those who deliver a service, those who receive it and those who pay for it [20].
This led the authors to propose a shift from the original
Porter equation (Value = Outcome/Cost) to a morenuanced one, identifying service as a specific component (Value = Quality + Service/Cost). Quality may
incorporate elements such as employee productivity (for
employers) that matter little to other groups. Service may
include elements such as out-of-pocket expenses (for
patients) that are not prime considerations for physicians
or employers.
Value exists as a concept only in the eyes of the recipient. In economic terms, it can be considered as the total
amount of money a customer would be willing to pay for
a service. Value creation involves providing new services
or improving existing services to increase their worth to
the recipient, at little or no additional cost [19].
Where is the value of radiology delivered?
(a) Prevention
(a) Disease prevention (screening and predictive
imaging biomarkers)
(b) Reassurance, e.g. confirmation of the absence
of disease, eliminating the need for further
(potentially-expensive) investigation
(c) Radiation protection – optimising protocols
to minimise risk, preventing unnecessary or
duplicate studies.
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(b) Detection
(a) Population-based screening programs
(b) Identification of abnormalities accounting for
clinical presentations
(c) Diagnosis
(a) Disease staging, facilitating decisions about
appropriate management
(b) Provision of high-level subspecialist imaging
interpretation, shown to improve staging and
management decision-making [21]
(c) Image-guided lesion biopsy for histopathology
(d) Clinical decision-support – facilitating the
choice of the most-helpful and most-targeted
investigation to answer a clinical question and
indicating clinical situations in which imaging
is likely to represent low-value care.
(d) Delivery and monitoring of therapy
(a) Evaluation of patient progress during treatment; early treatment monitoring (responders
vs. non-responders)
(b) Development & utilisation of imaging biomarkers, to facilitate earlier disease detection, prediction of response to treatment, reduction in
invasive testing and improvements in targeted
treatments. Imaging biomarkers add value to
pre-treatment workup, treatment choice and
follow-up for many conditions. Biomarkers
can act as surrogate endpoints in clinical trials,
leading to more rapid translation of research to
clinical practice [22].
(c) Interventional radiology – minimally-invasive
investigations and treatments, often resulting
in speedier recovery than after formal surgery
(e) Prognosis
(a) Confirmation of disease resolution, facilitating
cessation of treatment
(f ) Other
(a) Teleradiology linking rural communities and
highly specialised radiology centres/hospitals
(b) Other non-interpretive activities, e.g. teaching,
multi-disciplinary team meeting preparation
and participation, research and administrative
work [23]
(c) Communication to patients, the public, the
medical community and other interested stake-

Page 5 of 8

holders. This includes critical test result notifications to ensure timely clinical handover and
emergency care [1].

How is value measured?
Impacting therapeutic decisions, improving patient outcomes and benefits for society as a whole are the core
aspects of value creation in radiology. Quantifying radiology’s impact requires more precise, reproducible, and
practically-measurable imaging-specific and clinicallyrelevant metrics linked to agreed and important health
outcomes. Future radiology research must place greater
emphasis on Fryback and Thornbury’s higher-level outcomes [11] to best demonstrate radiology’s value. While
a diagnostic test such as breast MRI, performed using the
same equipment, scanning parameters, and interpreter,
may have equivalent diagnostic performance in two different patient groups, its efficacy will likely be greater in
women with specific characteristics (e.g. BRCA1 mutation carriage).
To whom is the value of radiology delivered?
Ultimately, the recipient of healthcare services (and
value) is the patient, and, to some extent, their loved
ones. However, except in the context of screening,
requests for diagnostic radiology studies usually come
from referring clinicians who seek radiology’s input, and
directly receive the output (reports). Referring clinicians
can be considered as “intermediate customers”. When
optimally utilised, the value of radiology is also delivered
to hospitals and health services and to the economy as a
whole [1].
Patients do not want an ultrasound, CT, or MRI; they
want an answer to a clinical question. The primary
purpose of diagnostic radiology is to answer clinical
questions using medical imaging, and to help guide
patient care in the most effective way possible, including in some instances not performing an imaging test
[1]. Fundamentally, diagnostic radiology is concerned
with acquisition, utilisation, and dissemination of information [1]. Process metrics can be used to measure
aspects of value delivery including timeliness of information delivery, application of appropriate levels of
specialisation to interpretation (and thus to accuracy of
information acquisition), and tailoring of information
delivery to the needs of different types of intermediate customers (e.g. emergency care, primary care, nonurgent specialty care) [19].
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What is the goal?
Radiology is a key component of healthcare, impacting
greatly on patient outcomes, and must be considered a
vital element of VBH. Radiology must be part of any calculation of value metrics, and resourcing decisions based
on such calculations must take account of the need to
resource radiology adequately to maintain its value contribution [15].
Radiologists and radiology departments have a responsibility to help define and create value wherever possible
and to optimise the yield from what we do. In addition,
we need to publish research reporting on radiology’s
impact on therapeutic decisions, patient outcomes, and
societal benefits, especially when targeting select patient
populations for new medical imaging applications, when
associated healthcare costs may be large [15]. Traditional
radiology research metrics like diagnostic and technical
accuracy may be sufficient to demonstrate a value contribution for tests and procedures with smaller, well-defined
target populations and/or clear impacts on patient outcome [15]. When assessing the societal value of radiology, we need different robust, reproducible, and clinically
relevant outcome metrics to objectify and quantify the
value contributed by radiology [24].
Steps which can support this endeavour include:
1 Engaging directly and often with referring clinicians
to better understand their practices and needs, and
to develop mutual relationships of trust and understanding.
(a) Supporting evidence-based guidelines to assist
referrers in requesting appropriate imaging
or interventional procedures specific to the
patient’s clinical history or condition (e.g., ESR
iGuide, ACR Appropriateness Criteria, Choosing Wisely) [25–28].
(b) Reinforcing the use of such guidelines in collaboration with referrers enhances the quality
of patient care and enables radiologists to contribute value through efficacious resource use.
2 Understanding the varying needs of referrers (e.g.
rapid turnaround, 24/7 availability for emergency
care, subspecialty expertise, multidisciplinary input
for complex, non-emergency cases), and building
services to encompass all needs without conflict [1].
3 Ensuring that radiology departments work cohesively
as a whole, operating as teams to ensure enterprisewide standards are achieved, cross-cover and -support are freely available, and isolated silos do not
develop to the detriment of other areas of service.
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4 Structuring department work plans to meet referrers’
needs, e.g. making protected time available for multidisciplinary team activity.
5 Utilising available resources and tools (e.g. structured
reporting, clinical decision support tools, AI tools)
and, where possible, augmenting resources to optimise workflow to minimise patient waiting times for
studies, and (if achievable) shorten hospital stays
6 Engaging directly with patients, to answer their questions and offer explanation of their imaging findings,
as appropriate [1].
7 Optimising information (images, reports etc.)
exchange using appropriate IT tools, e.g. provision of
urgent report notifications, clinical decision support
tools and use of structured reporting, including links
to key images demonstrating positive findings [29].
8 Constant quality monitoring and promotion of a culture of constant quality improvement [19].
9 Experimental research, including efforts to establish
higher-level value contributions: supporting today’s
radiology research is a commitment to improving
tomorrow’s radiology practice [30].
These principles are inherent to several value-based
imaging initiatives, including the ACR’s Imaging 3.0 [31],
the RSNA’s Radiology Cares [32], and the RANZCR’s
Inside Radiology [33]. Optimisation of value-creation
and resource utilisation demands cooperation among
all those involved, including referrers, patients, healthcare administrators, and radiologists. Patients must
understand that their specific needs are best served by
a flexible, responsive healthcare system that applies the
investigation best suited to answering the relevant clinical question at that particular point in their care, with the
greatest safety. Referrers must work with radiologists to
optimise resource utilisation, justified and optimised to
the specific patient’s circumstance at the time, in order
to maximise value. All parties must educate themselves
about methodologies used to determine costs and value,
and must understand that their choice of actions and
decisions may have influences that go far beyond the narrow specifics of any one episode of patient care or siloed
departmental or hospital budgets. Cost calculation and
allocation is complex and relative, depending on the reference points used [17].

Conclusion
VBH as a concept is here to stay. It will underpin future
planning and resource allocation in all aspects of medical care. Models of defining value remain in evolution.
Narrow models which commence the consideration of
value with the making of a diagnosis are incomplete, and
misrepresent the entire healthcare resource allocation
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for that patient. Radiology’s contribution to healthcare
is broad, encompassing many aspects that go beyond
traditional study report creation. Objectifying this contribution by stating the impact on therapeutic decisions, patient outcomes, and societal benefits ensures
radiologists’ future role. Radiologists, working singly
or as parts of collective departments, must understand
the principles underpinning cost allocation and the
value-chain concept, and must take VBH into account
when planning, developing and delivering their services.
Equally, referrers, who impose costs without incurring
them directly (by utilising services which are paid for by
patients or third party payers) must have greater accountability for their impact on the cost of medical imaging and for ensuring resources are utilised for optimum
patient health benefit. Managers who resource and plan
healthcare services must understand how under-resourcing of potential bottlenecks in service delivery, such as
radiology facilities, can impact negatively on outcomes
for patients. By embracing VBH principles, and striving
to create value where possible, radiology can contribute greatly to moving from a volume-driven system to a
value-driven one, where as many investigations or interventions as possible contribute positively to patient outcomes [1]. This will require renewed willingness on the
part of radiologists to participate in team-based clinical decision-making with other specialists. It will also
require willingness on the part of referrers to work with
radiologists to ensure the most appropriate use of radiology resources, services and personnel [1].
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